Dual Targeting of the Epidermal Growth Factor Receptor Using Combination of Nimotuzumab and Erlotinib in Advanced Non-Small-Cell Lung Cancer with Leptomeningeal Metastases: A Report of Three Cases

Leptomeningeal metastases (LM) occur in 3–5% of patients with advanced non-small-cell lung cancer (NSCLC) and are associated with a dismal prognosis. We report three cases of NSCLC with LM who were treated with the combination of nimotuzumab and erlotinib. Magnetic Resonance Imaging (MRI) evaluation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Xu, Hongyu, Zhou, Lin, Lu, You, Su, Xiaomei, Cheng, Peng, Li, Dong, Gao, Hui, Li, Hua, Yuan, Weiwei, Zhang, Ling, Zhang, Tao
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Case Series
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6982442/
https://ncbi.nlm.nih.gov/pubmed/32021306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S230399
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados